CB1 receptor antagonism/inverse agonism increases motor system excitability in humans

European Neuropsychopharmacology

Volumn 22, Issue 1, 2012, Pages 27-35

  Oliviero, A ^a   Arevalo Martin, A ^a   Rotondi, M ^b   Garcia Ovejero D ^a   Mordillo Mateos, L ^a   Lozano Sicilia, A ^a   Panyavin, I ^a   Chiovato, L ^a   Aguilar, J ^a   Foffani, G ^a   Di Lazzaro, V ^c   Molina Holgado, E ^a  

^a HOSPITAL NACIONAL DE PARAPLÉJICOS   (Spain)

^b UNIVERSITY OF PAVIA   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

CB1; Motor cortex; Rimonabant; Spinal cord; Transcranial magnetic stimulation

Indexed keywords

CANNABINOID 1 RECEPTOR; RIMONABANT;

ADULT; ARTICLE; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; HUMAN EXPERIMENT; INVERSE AGONISM; MALE; MOTOR CORTEX; MOTOR SYSTEM; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; SPINAL CORD MOTONEURON;

ADULT; DRUG INVERSE AGONISM; HUMANS; MALE; MOTOR CORTEX; MOTOR NEURONS; NEURAL INHIBITION; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84155168068     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2011.04.004     Document Type: Article

References (49)

1. Baker D., Pryce G., Croxford J., Brown P., Pertwee R., Huffman J., Layward L. Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature 2000, 404:84-87.
2. Chevaleyre V., Takahashi K., Castillo P. Endocannabinoid-mediated synaptic plasticity in the CNS. Annual Review of Neuroscience 2006, 29:37-76.
3. Clarke R., Harris J., Jenkins S., Witton S. Cannabinoidergic and opioidergic inhibition of spinal reflexes in the decerebrated, spinalized rabbit. Neuropharmacology 2001, 40(4):570-577.
4. Di Lazzaro V., Oliviero A., Profice P., Saturno E., Pilato F., Insola A., Mazzone P., Tonali P., Rothwell J.C. Comparison of descending volleys evoked by transcranial magnetic and electric stimulation in conscious humans. Elecroencephalography and Clinical Neurophysiology 1998, 109:397-401.
5. Di Lazzaro V., Restuccia D., Oliviero A., Profice P., Ferrara L., Insola A., Mazzone P., Tonali P., Rothwell J.C. Effects of voluntary contraction on descending volleys evoked by transcranial stimulation in conscious humans. The Journal of Physiology 1998, 508:625-633.
6. Di Lazzaro V., Oliviero A., Profice P., Insola A., Mazzone P., Tonali P., Rothwell J.C. Effects of voluntary contraction on descending volleys evoked by transcranial electrical stimulation over the motor cortex hand area in conscious humans. Experimental Brain Research 1999, 124:525-528.
7. Di Lazzaro V., Rothwell J.C., Oliviero A., Profice P., Insola A., Mazzone P., Tonali P. Intracortical origin of the short latency facilitation produced by pairs of threshold magnetic stimuli applied to human motor cortex. Experimental Brain Research 1999, 129:494-499.
8. Di Lazzaro V., Oliviero A., Mazzone P., Pilato F., Saturno E., Insola A., Visocchi M., Colosimo C., Tonali P.A., Rothwell J.C. Direct demonstration of long latency cortico-cortical inhibition in normal subjects and in a patient with vascular parkinsonism. Clinical Neurophysiology 2002, 113(11):1673-1679.
9. Di Lazzaro V., Oliviero A., Profice P., Pennisi M.A., Pilato F., Zito G., Dileone M., Nicoletti R., Pasqualetti P., Tonali P.A. Ketamine increases human motor cortex excitability to transcranial magnetic stimulation. The Journal of Physiology 2003, 547(Pt 2):485-496.
10. Di Lazzaro V., Oliviero A., Pilato F., Saturno E., Dileone M., Mazzone P., Insola A., Tonali P.A., Rothwell J.C. The physiological basis of transcranial motor cortex stimulation in conscious humans. Clinical Neurophysiology 2004, 115(2):255-266.
11. Di Marzo F. Targeting the endocannabinoid system: to enhance or reduce?. Nature Reviews. Drug Discovery 2008, 7:438-455.
12. El Manira A., Kyriakatos A., Nanou E., Mahmood R. Endocannabinoid signaling in the spinal locomotor circuitry. Brain Research Reviews 2008, 57(1):29-36.
13. Farquhar-Smith W., Egertova M., Bradbury E., McMahon S., Rice A., Elphick M. Cannabinoid CB1 receptor expression in rat spinal cord. Molecular and Cellular Neuroscience 2000, 15(6):510-521.
14. Fernandez-Ruiz J. The endocannabinoid system as a target for the treatment of motor dysfunction. British Journal of Pharmacology 2009, 156:1029-1040.
15. Fitzgerald P.B., Williams S., Daskalakis Z.J. A transcranial magnetic stimulation study of the effects of cannabis use on motor cortical inhibition and excitability. Neuropsychopharmacology 2009, 34(11):2368-2375.
16. Freund T., Katona I., Piomelli D. Role of endogenous cannabinoids on synaptic signaling. Physiological Reviews 2003, 83:1017-1066.
17. Garcia-Ovejero D., Arevalo-Martin A., Petrosino S., Docagne F., Hagen C., Bisogno T., Watanabe M., Guaza C., Di Marzo V., Molina-Holgado E. The endocannabinoid system is modulated in response to spinal cord injury in rats. Neurobiology of Disease 2009, 33(1):57-71.
18. Gilbert P. A comparison of THC, nantradol, nabilone, and morphine in the chronic spinal dog. Journal of Clinical Pharmacology 1981, 21:311S-319S.
19. Gough A., Olley J. Delta-9-tetrahydrocannabinol and the extrapyramidal system. Psychopharmacology 1977, 54(1):87-99.
20. Hallett M. Transcranial magnetic stimulation and the human brain. Nature 2000, 406:147-150.
21. Hegyi Z., Kis G., Hollo K., Ledent C., Antal M. Neuronal and glial localization of the cannabinoid-1 receptor in the superficial spinal dorsal horn of the rodent spinal cord. The European Journal of Neuroscience 2009, 30:251-262.
22. Heifets B., Castillo P. Endocannabinoid signaling and long-term synaptic plasticity. Annual Review of Physiology 2009, 71:283-306.
23. Herkenham M., Lynn A., Little M., Johnson M., Melvin L., de Costa B., Rice K. Cannabinoid receptor localization in brain. Procedings of the National Academy of Science 1990, 87(5):1932-1936.
24. Herkenham M., Lynn A., Johnson M., Melvin L., de Costa B., Rice K. Characterization and localizatino of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. The Journal of Neuroscience 1991, 11:563-583.
25. Jones D. End of the line for cannabinoid receptor 1 as an anti-obesity target?. Nature Reviews. Drug Discovery 2008, 7:961-962.
26. Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M., Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiological Reviews 2009, 89:309-380.
27. Kujirai T., Caramia M., Rothwell J., Day B., Thompson P., Ferbert A., Wroe S., Asselman P., Marsden C. Corticocortical inhibition in human motor cortex. The Journal of Physiology 1993, 471:501-519.
28. Kyriakatos A., El Manira A. Long-term plasticity of the spinal locomotor circuitry mediated by endocannabinoid and nitric oxide signaling. The Journal of Neuroscience 2007, 27(46):12664-12674.
29. Moreira F., Crippa J. The psychiatric side-effects of rimonabant. Revista Brasileira de Psiquiatria 2009, 31(2).
30. Ong W., Mackie K. A light and electron microscopic study of the CB1 cannabinoid receptor in the primate spinal cord. Journal of Neurocytology 1999, 28:39-45.
31. Orth M., Rothwell J.C. The cortical silent period: intrinsic variability and relation to the waveform of the transcranial magnetic stimulation pulse. Clinical Neurophysiology 2004, 115(5):1076-1082.
32. Padwal R., Majumdar S. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 2007, 369(9555):71-77.
33. Paulus W., Classen J., Cohen L.G., Large C.H., Di Lazzaro V., Nitsche M., Pascual-Leone A., Rosenow F., Rothwell J.C., Ziemann U. State of the art: Pharmacologic effects on cortical excitability measures tested by transcranial magnetic stimulation. Brain Stimulation 2008, 1(3):151-163.
34. Petro D., Ellenberger C. Treatment of human spasticity with delta 9-tetrahydrocannabinol. Journal of Clinical Pharmacology 1981, 21(8):413S-416S.
35. Richardson J., Kilo S., Hargreaves K. Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain 1998, 75(1):111-119.
36. Romero J., Hillard C.J., Calero M., Rabano A. Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study. Brain Research. Molecular Brain Research 2002, 100:85-93.
37. Sanger T.D., Garg R.R., Chen R. Interaction between two different inhibitory systems in the human motor cortex. The Journal of Physiology 2001, 530:307-317.
38. Tokimura H., Di Lazzaro V., Tokimura Y., Oliviero A., Profice P., Insola A., Mazzone P., Tonali P., Rothwell J. Short latency inhibition of human hand motor cortex by somatosensory input from the hand. The Journal of Physiology 2000, 523(2):503-513.
39. Tramposch A., Sangdee C., Franz D., Karler R., Turkanis S. Cannabinoid-induced enhancement and depression of cat monosynaptic reflexes. Neuropharmacology 1981, 20(6):617-621.
40. Turkanis A., Karler R. Effects of delta-9-tetrahydrocannabinol on cat spinal motoneurons. Brain Research 1983, 288(1-2):283-287.
41. Turkanis A., Karler R. Influence of different barbiturate anesthetics on delta-9-tetrahydrocannabinol effects on spinal monosynaptic reflexes. Life Sciences 1983, 32(15):1675-1681.
42. Turkanis A., Karler R. Cannabidiol-caused depression of spinal motoneuron responses in cats. Pharmacology, Biochemistry, and Behavior 1986, 25(1):89-94.
43. Valls-Solé J., Pascual-Leone A., Wassermann E.M., Hallett M. Human motor evoked responses to paired transcranial magnetic stimuli. Electroencephalography and Clinical Neurophysiology 1992, 85(6):355-364.
44. Wilson R., Nicoll R. Endocannabinoid signaling in the brain. Science 2002, 296(5568):678-682.
45. Ziemann U., Lonnecker S., Steinhof B.J., Paulus W. The effect of lorazepam on the motor cortical excitability in man. Experimental Brain Research 1996, 109:127-135.
46. Ziemann U., Lonnecker S., Steinhoff B.J., Paulus W. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Annals of Neurology 1996, 40:367-378.
47. Ziemann U., Tergau F., Wassermann E.M., Wischer S., Hildebrandt J., Paulus W. Demonstration of facilitatory I-wave interaction in the human motor cortex by paired transcranial magnetic stimulation. The Journal of Physiology 1998, 511:181-190.
48. Ziemann U., Tergau F., Wischer S., Hildebrandt J., Paulus W. Pharmacological control of facilitatory I-wave interaction in the human motor cortex. A paired transcranial magnetic stimulation study. Electroencephalography and Clinical Neurophysiology 1998, 109:321-330.
49. Ziemann U., Chen R., Cohen L.G., Hallett M. Dextromethorphan decreases the excitability of the human motor cortex. Neurology 1998, 51(5):1320-1324. Nov.